Jeffrey Tong - Profile and Investment Details

Investor Profile

Jeffrey Tong is a Venture Capital, Private Equity Firm, Investor based in Menlo Park, California, United States with a diverse investment portfolio that includes companies such as Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics, Constellation Pharmaceuticals, Jounce Therapeutics, Motus TherapeuticsPanOptica, Warp Drive Bio, Editas Medicine, Ember Therapeutics, MOMA Therapeutics, Relay Therapeutics, Decibel Therapeutics, CytomX Therapeutics, Topica Pharmaceuticals, Cibiem, Inc., Alcresta, Rhythm Metabolic, Agios Pharmaceuticals, Rheos Medicines, Lotus Tissue Repair, Nora Therapeutics, Bluebird Bio, Delinia, Corvia Medical, Afferent Pharmaceuticals, Foundation Medicine, Fulcrum Therapeutics, Voyager Therapeutics, Seventh Sense Biosystems, Maze Therapeutics, Neon Therapeutics, TARIS Biomedical, NinePoint Medical, Asher Bio, MyoKardia, Thrive Earlier Detection, Celsius Therapeutics, Igenica, Cedilla Therapeutics, Casma Therapeutics, Edimer Pharmaceuticals, Pliant Therapeutics, Sesen Bio, Inc., Element Science, Insitro, Soffio Medical, Takko, Revolution Medicines, Fortmatic, Faze Medicines, Ambys Medicines, Global Blood Therapeutics, Kala Pharmaceuticals, Rhythm Pharmaceuticals, Nurix Therapeutics, Tango Therapeutics, SAGE Therapeutics, Allena Pharmaceuticals, . Over time, Jeffrey Tong has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jeffrey Tong is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Autoimmune Diseases, Wellness, Women Founded, Rare Diseases, Healthcare Innovation, Life Science, Engineering, Medical Technologies, Startups, Business Development, Biotechnology, Medical Devices, Drug Development, Entrepreneurship, Genomics, Wearable Technology, Precision Medicine, Innovation, Clinical Trials, Gene Therapy, Health Diagnostics, Medical, Information Technology, B2B, Therapeutics, Cellular Therapy, Media and Entertainment, Machine Learning, Pharmaceuticals may find it worthwhile to explore potential connections with Jeffrey Tong, as their portfolio suggests a familiarity and interest in this area.

Understanding Jeffrey Tong’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.